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Abstract: Manna, a very singular vegetable product derived from the spontaneous solidification of
the sap of some Fraxinus species, has long been known for its mild laxative and emollient properties.
In this work, a hydro-alcoholic extract of manna (HME) from Sicilian Fraxinus angustifolia Vahl was
investigated using HPLC-DAD to find phenol components and using chemical and biological in vitro
assays to determine its reducing, antioxidant and anti-inflammatory capacity. We identified elenolic
acid, tyrosol, hydroxytyrosol, catechin, fraxetin, verbascoside, gallic acid, procyanidin-B1, and luteolin
3,7 glucoside, in order of abundance. Measurements of total antioxidant activity by Folin-Ciocalteu
reaction and ferric reducing ability (FRAP), as well as of scavenger activity towards ABTS•+, DPPH•,
and perferryl-myoglobin radicals, showed that the phytocomplex effectively reduced oxidants with
different standard potentials. When compared with vitamin E, HME also behaved as an efficient
chain-breaking antioxidant against lipoperoxyl radicals from methyl linoleate. In cellular models for
oxidative stress, HME counteracted membrane lipid oxidation of human erythrocytes stimulated
by tert-butyl hydroperoxide and prevented the generation of reactive oxygen species, as well as
the GSH decay in IL-1β–activated intestinal normal-like cells. Moreover, in this in vitro intestinal
bowel disease model, HME reduced the release of the pro-inflammatory cytokines IL-6 and IL-8.
These findings may suggest that manna acts as an antioxidant and anti-inflammatory natural product
in humans, beyond its well-known effects against constipation.
Keywords: manna; Fraxinus; manna bioactivity; phytochemicals; antioxidant; reducing power; red
blood cell oxidation; intestinal bowel disease model
1. Introduction
Known for centuries within the ethno-botanical field, the Sicilian “manna” is a very singular
vegetable product obtained by the spontaneous solidification of the phloem sap collected from some
Fraxinus species (Oleaceae). The production of manna requires a number of special conditions. High
temperatures, low humidity and a low temperature range are necessary for the manna trees to be
grown [1]. Some areas of the Madonie Mountains in Northern Sicily are ideal pedoclimatic niches
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for the cultivation of the ash trees, from which the sap is obtained and gathered in accordance with
a traditional procedure. During the summer months, the tree barks are engraved by hand with the
aid of specific tools to allow the sap to pour out. The spilled drops are allowed to solidify slowly and
spontaneously along nylon threads, thus forming characteristic rod-shaped forms of whitish colour,
known as cannolo manna [2,3]. At the same time, however, considerably more sap pours out along,
adheres to the bark and thickens on the trunk from which it is recovered as a dirty and poor-quality
product. Harvesting of the cannolo manna through the traditional method is tiring and time-consuming,
with a very modest yield. This has recently led us to develop and patent a procedure for purifying the
remarkably higher amounts of easily obtainable dirty manna (patent n.102015000061706).
Manna has long been acknowledged and used as a natural health remedy in popular medicine.
Besides serving as a mild laxative, it is applied in dermatological preparations for its soothing
and anti-aging effects, as well as in syrups, as fluidizing, expectorant and cough suppressant. Its
consumption is also recommended to regulate intestinal and hepatic function [4]. Sugars, mono- and
oligo- saccharides make up more than 80% of the dry weight of the Fraxinus manna [5,6]. Mannitol
is the main constituent, representing 50% of the total sugars. In addition, a recent phytochemical
characterization has revealed fatty acids and phenol components [5].
Measuring the reducing and antioxidant capacity of plant extracts is a way to determine
their bioactivity, and illustraties the plant’s potential benefits to people in a healthy state and in
patho-physiological conditions as well. In this study, we use a hydro-alcoholic solution to extract and
identify by HPLC-DAD the phenolic components of manna from F. angustifolia Vahl and investigate for
the first time reducing and antioxidant properties of the manna utilizing a number of well-established
chemical and biological screening methods in solution and in cells. Moreover, anti-inflammatory effects
of the extract were investigated in an in vitro model of intestinal bowel disease. Our results suggest
that, thanks to its biophenols, manna may contribute to counteracting oxidative stress, maintaining
cellular redox homeostasis and exerting anti-inflammatory effects.
2. Materials and Methods
2.1. Chemicals
Hydroxytyrosol, tyrosol, gallic acid, fraxetin, oleuropein, verbascoside, catechin, luteolin
3,7 glucoside, procyanidin B1, quercitin 3-O-glucoside, and elenoic acid were obtained from PhytoLab
GmbH & Co. (Vestenbergsgreuth Germany). Fraxetin was from Sigma Chemical Co (St Louis, MO).
Fetal bovine serum (FBS) was from Hyclone Perbio Sciences (Helsingborg, Skane Lan, Sweden). Human
interleukin (IL)-1β, IL-6 and IL-8 enzyme-linked immunosorbent assay (ELISA) Kits II were from
BD Biosciences Pharmingen (San Jose, CA, USA). HPLC-grade solvents and all other reagents and
chemicals were from Sigma Chemical Co (St. Louis, MO, USA).
2.2. Plant Material and Preparation of Hydrophilic Manna Extracts (HME)
Fraxinus angustifolia, Vahl subsp angustifolia, representing the majority of the species and the richest
source of manna among the ashes grown in the Madonie mountains, area of Castelbuono (Palermo,
Italy) [3], was the source of manna in August 2018. Five lots of dirty, low quality manna from five
different ashes were scraped from the bark, collected together and purified from rough contaminations
following the procedure of patent n.102015000061706.
For the extraction procedure, manna samples (10 g) were completely dissolved in 30 mL distilled
water. Then, two volumes of methanol (MeOH) were added and extraction carried out at room
temperature (25 ± 2 ◦C) and in darkness for 1 h. afterwards, the mixtures were allowed to stand 4 h
at 4 ◦C before centrifugation (3000 g, 10 min) to remove the crystallized sugars. The supernatants
were withdrawn, filtered in a Büchner funnel through a 0.45 µm filter (Millipore, Billerica, MA) and
submitted to rotary evaporation at 35 ◦C. Water residual from the solution was then eliminated by
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cryodessication. Dried samples of HME were stored at −80 ◦C and used within two months. Before the
use, dried HME was resuspended in suitable volumes of 5 mM phosphate buffer saline, (PBS), pH 7.4.
2.3. Determination of Phenolic Compounds by HPLC-DAD
Dried HME was resuspended in distilled water (0.5 g manna equivalent/mL) which was purified
using a cartridge Bond elut C18 (500 mg 6 mL) Agilent column (Santa Clara, CA, USA) according to
the manufacturer’s instructions. Phenols were eluted with methanol (15 mL) and the solvent was
removed under vacuum. The residue was dissolved in 1:1 (v/v) methanol-water at a final concentration
of 30 mg manna equivalent/mL for HPLC analysis.
HPLC-DAD analyses were carried out in duplicate and performed using an Agilent 1100 Infinity,
equipped with a diode array detector (DAD) and with a 150 × 4.6 mm i.d., 2,7 µm Ascentis Express C
18 column. The mobile phases were H2O/H3PO4 (99:1, solvent A) and MeOH/ACN/H3PO4 (49,5:49,5:1,
solvent B) the gradient used was: concentration the solvent A of 95% going to 77% (34 min), maintain
77% (3 min), 74% (60 min), 60% (85 min), 20% (90 min) and 0% (92 min), total time 105 min. The
column temperature was maintained at 25 ◦C. The flow was 1 mL/min and the injection volume was
15 µL. The profiles chromatograms were recorded from 190 to 500 nm and monitored at 240, 280, 330 e
346 nm ± 2 nm. The compounds were quantified by a five-point regression curve on the basis of the
standards obtained from commercial suppliers. The retention time and the peak area were measured
using the ChemStation software (Agilent Technologies Italia, Milan, Italy).
2.4. Reducing Capacity Tests
2.4.1. Folin-Ciocalteu Reaction
Folin-Ciocalteu reaction, based on the reduction of phosphotungstic–phosphomolybdic acid
(Folin-Ciocalteu’s reagent) to blue reaction products in alkaline solution, was used to quantify the
total antioxidant activity (TAA). Aliquots (100 µL) of properly diluted HME (extracts from 2–20 mg
manna, analysed in duplicate, in a 100 µL final volume) were mixed 3 mL of 2% sodium carbonate
followed by the addition of 100 µL Folin-Ciocalteu’s reagent diluted 1:1 with water. The mixture was
allowed to stand for 60 min at room temperature, in darkness. Then the absorbance was measured
spectrophotometrically at 765 nm against a blank using a Beckman DU 640 spectrophotometer (Beckman,
Milan, Italy). Quantitation was performed by curves constructed with gallic acid (5–100 µg/mL) and
results were expressed as mg of gallic acid equivalents (GAE) per g manna.
2.4.2. Ferric Ion Reducing Antioxidant Power (FRAP) Assay
Ferric ion reducing capacity of manna extract was tested using FRAP assay [7], according to
Attanzio et al. [8].
2.5. Radical Scavenging Assays
2.5.1. ABTS+ Radical Scavenging Assay
The radical-scavenging capacity of HME was evaluated using the 2,2′-azino-bis(3-etilbenzotiazolin-
6-sulfonic acid (ABTS) radical cation decolourization assay [9].
2.5.2. DPPH Radical Scavenging Assay
2,2-Diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging activity was measured according
to Brand-Williams et al. [10].
2.5.3. Hypervalent Iron Mb Species Reduction Assay
Oxidation of horse met-myoglobin (met-Mb) to perferryl-myoglobin radical (•Mb[FeIV=O])
was carried out, at 37 ◦C, in a reaction mixture containing 100 µM heme-protein in 0.1 M sodium
acetate buffer, pH 5.0, supplemented with 100 µM H2O2, either in the absence or in the presence
of 10 µL of properly diluted HME. Spectrophotometric scans were monitored at 400–800 nm before
and 5 min after the H2O2 addition [11]. The hypervalent iron-concentration was calculated from the
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absorbance at 556 nm, the point at which the two forms differ most (ε = 3.6 mM cm−1) [12]. Myoglobin
spectral changes in the visible region were measured on a DU 640 spectrophotometer equipped with a
temperature controller.
In all assays described, samples of HME were analysed in duplicate, at three different dilutions,
within the linearity range of the assay. The ABTS•+, DPPH• and •Mb[FeIV=O] radical scavenging
capacities of HME were quantified in comparison with Trolox, the water-soluble analogue of vitamin
E, and the results expressed as Trolox equivalents (TE) per g of manna. Trolox was prepared as ethanol
solution and the final concentration of ethanol in the assay mixture did not exceed 0.1%.
2.5.4. Peroxyl Radical-Scavenging Assay in Solution
Peroxidation of methyl linoleate was performed by incubating 300 mM linoleic acid methyl ester
(LAME) and 0.5 mM 2,2′-azobis(2,4-dimethyl-valeronitrile) (AMVN), in a final methanol volume of
1.0 mL, in a water bath at 37 ◦C, under air. Portions of the mixture (10 µL) were taken at intervals
and injected onto a Supelco SupelcosilTM (Bellafonte, PA, USA) LC-18 column (250 × 4.6 mm i.d.,
5 µm), equilibrated, and then eluted with methanol at a flow rate of 1.0 mL/min. Quantitation was
by reference to a standard curve constructed with known amounts of linoleic acid hydroperoxide
(13(S)-hydroperoxy-(9Z,11E)-octadecadienoic acid). Aliquots (10 µL) of properly diluted HME or
vitamin E (5 µM) in methanol were added to the methanol solution of methyl linoleate and allowed to
equilibrate at 37 ◦C for 60 s, before adding the azoinitiator.
2.6. Antioxidant Activity in Red Blood Cells (RBCs)
Blood samples were obtained from healthy individuals by venipuncture with informed consent.
Ethylenediaminetetraacetic acid (EDTA) (1 mg/mL blood) was used as an anticoagulant. RBCs were
sedimented at 1000 g for 10 min and washed three times with phosphate-buffered saline (PBS), pH 7.4.
Supernatant and buffy coat were carefully removed by aspiration after each wash.
A 1% suspension of RBCs in PBS was incubated with 100 µM tert-butyl hydroperoxide for 4 hs
either in the absence or in the presence of various amounts of HME or vitamin E, used as a positive
control. After incubation, samples of the mixture were withdrawn and malondialdehyde (MDA), as an
index of lipid peroxidation, measured by HPLC as described by Tesoriere et al. [13].
2.7. Caco2 Cell Culture
Caco-2 cell line, derived from a human colon adenocarcinoma (American Type Culture Collection,
ATCC), was used between passages 10 and 30 and cultured at 37 ◦C in a humidified atmosphere of
CO2/air (5/95, v/v) in Dulbecco’s MEM with Glutamax supplemented with 25 mM HEPES, 10% (v/v)
heat-inactivated Fetal Bovine Serum (FBS), 1% penicillin (1 × 103 U/mL)-streptomycin (10 mg/mL), and
1% (v/v) non-essential amino acids (NEAA). Differentiated cells, grown to confluence for 18–21 days
in 12-well plates replacing the media every 3 days (cell density of 60 × 103 cells/cm2), were used for
the experiments. For the treatments only freshly prepared and filtered (0.2 µm) HME were used.
Cytotoxicity of the manna extract on Caco-2 cells was excluded by pilot studies using the Trypan Blue
exclusion method and the MTT assay.
2.7.1. Intracellular Reactive Oxygen Species (ROS) and GSH
Differentiated monolayers of Caco-2 were preincubated with or without HME, at the indicated
concentrations, for 1 h, and then were exposed to 25 ng/mL IL-1β for 24 h. Control cells
were incubated with medium alone. After treatment, intracellular levels of ROS and GSH were
cytofluorimetrically measured using the fluorescent probes 2′,7′-dichlorofluorescin diacetate (DCFDA)
or 5-chloromethylfluorescein diacetate (CMFDA), respectively. Briefly, DCFDA or CMFDA (10 µM and
1 µM final concentration, respectively) were added to the medium 30 min before ending the treatment
of the cells. The medium was then removed, and the cells were washed with PBS, resuspended in the
same buffer and immediately analysed using flow cytometry (Epics XLTM, Beckman Coulter, Fullerton,
CA) measuring fluorescence intensity in the FL-1 fluorescence channel at an excitation wavelength of
488 nm and emission wavelength of 530 nm. At least 10,000 events per sample were evaluated.
Antioxidants 2019, 8, 494 5 of 13
2.7.2. Cytokines
IL-8 and IL-6 concentrations were quantified using ELISA kits according to the manufacturer’s
instructions (DuoSet ELISA, R&D systems, Minneapolis, MN, USA).
2.8. Statistical Analysis
Results are given as means and standard deviations. Unless stated otherwise, three independent
observations were performed for each experiment thrice replicated. Calculations and graphs were
obtained using the INSTAT-3 statistical software (GraphPad Software, Inc., San Diego, USA) with a test
for normality followed by ANOVA, with Tukey’s correction for multiple comparisons. In all cases,
significance was accepted if the null hypothesis was rejected at the p < 0.05 level.
3. Results and Discussion
3.1. Polyphenols in HME
The quali/quantitative phytochemical content of vegetable extracts can vary by the extraction
solvent used, which in turn will affect the eventual reducing/antioxidant activity of the extracts.
Methanol has been reported to be the best extraction solvent for the large majority of plant
phytochemicals [14,15]. We carried out a hydro-methanolic extraction of manna, followed by
High-Performance Liquid Chromatography with Diode-Array Detection (HPLC-DAD) analysis,
and identified polyphenol compounds by the absorption spectra and retention times of authentic
compounds under our conditions (Figure 1). Elenolic acid and tirosol appear the most represented
polyphenolic components, followed by hydroxytirosol (Table 1). Highly-polar polyphenol verbascoside,
flavonoids such as cathechin, and B-type procyanidins, were also revealed, as well as gallic acid and
the coumarin fraxetin (Table 1). Finally, a minor amount of luteolin 3,7 glucoside was also found.
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phenolic compounds. Revelation was at 280 nm, 330 nm and 346nm.
In accordance with the chemotaxonomic closeness between Fraxinus and Olea genera, most of
the identified compounds occur in the olive fruit and leaves, and in olive oil [16,17]. Nonetheless, we
failed to find oleuropein, a major component of the genus Olea, also reported in F. angustifolia [18]. The
high amount of elenolic acid, hydroxytirosol and tyrosol (Table 1) is possibly the result of hydrolysis of
this seco-iridoid in its constituents, due to various factors, including light, temperature and bacterial
enzymes [4]. Because of their demonstrated pharmacological potential, interest in biological and
therapeutic effects of these phenols is huge [19].
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Table 1. Phytochemicals identified in manna extract from Fraxinus angustifolia Vahl.
Class Compound mg/Kg
Simple Phenols Gallic acid 4.12 ± 0.32
Coumarins Tyrosol 36.66 ± 0.25
Phenylpropanoids Hydroxytyrosol 13.33 ± 0.40
Flavonoids Fraxetin 4.74 ± 1.02
Secoiridoids Verbascoside 4.5 ± 0.21
Seco-iridoid derivative Catechin 5.86 ± 0.52
Luteolin 3,7 glucoside 1.45 ± 0.35
Procyanidin B1 3.69 ± 0.34
Quercitin 3-O-glucoside n.d.
Oleuropein n.d.
Elenolic acid 250 ± 4.78
Manna was extracted and treated as described in Methods. The values are the mean ± SD of two different extractions
and three HPLC runs for each sample (n = 6). n.d., not detected.
Quercitin glucoside (quercitin-3-O-a-L-rhamnopyranosyl-(1->6)-b-D-glucopyranoside,) has been
reported in the leaves and bark of Fraxinus angustifolia (Hosny Phytochemistry 1998), however we did
not find this compound in our manna extracts.
In accordance with our findings, a recent phytochemical profiling of ethyl acetate extracts of
manna from Fraxinus excelsior revealed the presence of simple phenolics, coumarins and iridoids, with
elenolic acid and tyrosol and hydroxytyrosol as the most represented [5].
3.2. Reducing Capacity of HME
The Folin-Ciocalteu assay, based on the formation of blue-coloured products by the reaction
between reducing compounds and reagent, is universally applied to reveal the total antioxidant activity
(TAA) measured as phenols, and quantified as gallic acid equivalents, in various natural matrices,
including dietary products [20]. HME showed a value of 1.22 ± 0.11 mg GAE per g of manna equivalent
(Table 2).
Table 2. Reducing capacity and Radical scavenger activity of manna extract.
TAA a
(mg GAE b/g)
FRAP
(mg AAE c/g)
ABTS•+
(mmol TE d/g)
DPPH•
(mmol TE d/g)
•Mb[FeIV=O]
Deactivation Rate
(mmol TE d/g min−1)
1.22 ± 0.11 0.22 ± 0.01 23.4 ± 1.51 0.51 ± 0.04 1.13 ± 0.09
a TAA; Total Antioxidant Activity. b GAE; Gallic Acid Equivalent. c AAE; Acid Ascorbic Equivalent. d TE; Trolox
Equivalent. Values are the mean ± SD of four determinations carried in triplicate.
The FRAP assay is based on the reduction of a FeIII-complex to the intensely blue coloured FeII-
form in the presence of reductants. The reducing activity of ascorbic acid is used as a reference. The
HME showed a ferric ion reducing capacity of 0.22 ± 0.01mg AAE per g of manna equivalent (Table 2).
3.3. Radical Scavenging Capacity of HME
The antiradical potential of the phenolic phytocomplex from HME was evaluated by the ability
to scavenge ABTS•+ and DPPH•, or reduce the perferryl-Mb radical (•Mb[FeIV=O]). The reducing
activity was expressed as equivalents of Trolox; the water-soluble analogue of vitamin E was used as
the reference compound.
The ABTS+ decolouration assay is widely considered appropriate to assess the antioxidant
properties of plant foods [21]. Under our conditions, HME from 1 g of manna showed a quenching
ability for the intensely coloured ABTS+ twenty times higher than Trolox (Table 2).
DPPH• is a stable, deep purple radical whose reaction with an electron donor reducing
agents [22,23] leads to loss of colour. It is also considered useful in providing information on the
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mechanism between the free radical and the antioxidant. We observed that HME, at 1g manna
equivalent, showed a DPPH• radical quenching capacity comparable to that of 0.51 ± 0.04 µmol Trolox.
Perferryl-Mb, generated by reaction of Met-Mb with hydrogen peroxide [24], is a very reactive
two-electrons oxidized form of Met-Mb, comprising an oxoferryl moiety and a globin-based tyrosyl
radical (•Mb[FeIV=O]) [25]. The measurement of the deactivation rate of perferryl-Mb by plant
phenols is a useful model to evaluate the reducing capacity of these compounds [26,27]. HME showed
a perferryl-Mb reducing rate of 1.13 ± 0.09 mmol Trolox/g manna equivalent for minute (Table 2).
The radical trapping capacity of compounds is not exclusively related to their redox potentials but
depends also on their distribution in the phase of the oxidizing probe. It is known that interaction
with the radical site in the Mb, or access to the heme hydrophobic pocket, requires suitable size,
three-dimensional structure and physico-chemical feature of the reducing compound [28]. Our results
may, therefore, indicate that phenolic components with such molecular properties are presents in the
manna extract involved in the observed reducing activity. Flavonoids, including catechin, have been
shown to be reductants of perferryl myoglobin radicals [28].
The capacity of manna components to interact and quench the Mb [FeIV=O] is highly interesting,
since such oxoferryl radical species are also formed during the catalytic cycle of eme-enzymes, such
as cyclooxygenase [29] and myeloperoxidase [30], suggesting that manna may have the potential to
intervene under inflammatory conditions.
On the whole, the results presented in Table 2 show that the mixture of polyphenols in manna can
neutralize a number of different oxidant or radical species, in assays characterized by chromogenic redox
reagents with different standard potentials. When considered altogether these assays provide a reliable
idea of the protective potential of manna. From a biological perspective, according to data from the
literature reporting results of these assays applied to fruits, vegetables and their derivatives [23,31,32],
the TAA of manna appears comparable to that reported for honeydew and the most fruits consumed
in the Mediterranean diet, such as grapes, peaches or nectarines [33]. In addition, taking into account
the values reported for sweetener products, the ABTS radical reducing capacity of 1 g manna appears
twice as high as that of one serving of maple syrup and raw cane sugar, and comparable to 20 mL of
honey [34].
3.4. Antioxidant Activity of HME in Solution
Due to the abundance of membrane phospholipids, lipoperoxyl radicals are the most easily
generated radical species in cells under either endogenous or exogenous oxidative insult. Phenol
and polyphenol compounds are potent reductants capable of neutralizing peroxyl radicals [35]. The
potential of HME to inhibit lipid oxidation was checked in methyl linoleate methanol solutions oxidized
by the azo-initiator AMVN. Vitamin E, the most important lipid antioxidant, was used as the positive
control. In the absence of manna, the addition of AMVN started a lipid oxidation evident as a steady
formation of lipid hydroperoxides, measured by HPLC (Figure 2). A net concentration-dependent
delay of the hydroperoxide formation (lag time) was observed in the presence of HME (Figure 2),
indicating that phenol components of manna had inhibited lipid oxidation. Vitamin E at 5 µM caused
a lag time of methyl linoleate hydroperoxide formation of 30 min (Figure 2). Interestingly, under our
conditions, phenol components in 1 mg manna show an antioxidant capacity two-times higher than
1 µM Vitamin E.
In these assays, antioxidant and substrate actually compete for thermally generated
peroxyl-radicals through decomposition of azo-compounds [36]. It may be important to mention that
the profile of the inhibition curve in the presence of manna, showing a definite lag time (Figure 2),
provides evidence that extract components actually react with and scavenge lipoperoxyl radicals [36].
Regarding this, it is known that hydroxytyrosol behaves as a chain-breaker by donating a hydrogen
atom to lipoperoxyl-radicals [37].
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Figure 2. 2,2′-azobis(2,4-dimethyl-valeronitrile) (AMVN)-induced oxidation of methyl linoleate in
methanol in the absence (control) or in the presence of HME. Oxidation conditions and HPLC analysis
of methyl linoleate hydoperoxides are reported in methods. Vit E was used as a positive control.
Each point represents the mean ± SD of three determinations carried out in triplicate with different
incubation mixtures.
3.5. Antioxidant Activity of HME in Human Cells
Human RBCs are particularly useful in the evaluation of the antioxidant properties of several
compounds [38,39]. These cells are particularly susceptible to endogenous oxidative damage because of
their specific role as oxygen carriers and for the abundance of polyunsatured lipid in their membranes.
When RBCs are exposed in vitro to organic hydroperoxides like tert-butyl hydroperoxide, the initial
decomposition of the peroxide in the presence of heme iron generates methemoglobin (met-Hb), H2O2
and a nu ber of oxyradicals from the hydroperoxide [40] that attack unsaturated lipids in membranes,
finally generating MDA.
Treatment of RBCs (1% ) it 100 µM tert-butyl hydroperoxide caused the formation of
3.2 ± 0.29 µmol MDA/106 cells (n = 4) after 4 h incubation. HME from 0.3 to 2.0 mg ma na inhibited
the MDA production in a dose-d pendent manner (Figure 3), with a c lculated IC50 (i.e., the amount
that inh bits MDA formation by 50%) of 0.24 ± 0.04 g manna equivalent (n = 4).
Antioxidants 2019, 8, x FOR PEER REVIEW 9 of 14 
 
Figure 3. HME inhibits membrane lipid oxidation of human erythrocytes stimulated by tert-butyl 
hydroperoxide. Cell oxidation conditions and HPLC analysis of malondialdehyde (MDA) are 
reported in the methods section. Vit E was used as a positive control. Each point represents the mean 
± SD of three determinations carried out in triplicate with different incubation mixtures. 
3.6. Anti-Oxidant Effects of HME in Differentiated Caco-2 Cells Stimulated by IL-1 
ROS play important roles as signaling molecules in normal physiology, as well as in 
inflammatory diseases and cancer [42,43]. In this scenario, the effects of redox-active phytochemicals 
that may maintain the cell-specific redox tone was investigated.  
Differentiated Caco-2 cells exposed to IL-1 are considered an established model of an inflamed 
human intestinal barrier [44], in which stimulated ROS over-production triggers the activation of 
redox-sensitive intracellular signalling cascades that promote the inflammatory response. When 15 
day-post confluent IL-1-treated Caco-2 cell monolayers were treated for 3 h with IL-1, 
cytofluorimetric analysis with DCFDA showed a net increment of intracellular ROS levels respect to 
untreated cells (Figure 4 A). As a consequence, the intracellular GSH concentration, 
cytofluorimetrically measured by CMFDA probe, appeared significantly decreased of about 40% 
(Figure 4 B). Co-incubation of the cells with IL-1 and HME in the range from 0.2 to 1.0 mg/mL manna 
equivalent, inhibited both ROS generation (Figure 4 A) and the GSH loss (Figure 4 B) in a 
concentration-dependent manner. HME at 1 mg manna equiv /mL was able to completely prevent 
the IL-1-induced oxidative stress of the cells (Figure 4). 
Figure 3. HME inhibits membrane lipid oxidation of human erythrocytes stimulated by tert-butyl
hydroperoxide. Cell oxidation conditions and HPLC analysis of malondialdehyde (MDA) are reported
in the methods section. Vit E was used as a positive control. Each point represents the mean ± SD of
three determinations carried out in triplicate with different incubation mixtures.
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In our system the IC50 of vitamin E, used as a positive control, was 1.1 ± 0.08 µM (n = 4) (Figure 3).
Overall, these findings indicate that the phenol components of manna may act as very effective
antioxidants and protect red blood cell membrane lipids from oxidation. It is worth mentioning that
hydroxytyrosol at low micromolar concentration has been shown to protect red blood cells from
oxidative damage stimulated by hydrogen peroxide [41].
3.6. Anti-Oxidant Effects of HME in Differentiated Caco-2 Cells Stimulated by IL-1β
ROS play important roles as signaling molecules in normal physiology, as well as in inflammatory
diseases and cancer [42,43]. In this scenario, the effects of redox-active phytochemicals that may
maintain the cell-specific redox tone was investigated.
Differentiated Caco-2 cells exposed to IL-1β are considered an established model of an
inflamed human intestinal barrier [44], in which stimulated ROS over-production triggers the
activation of redox-sensitive intracellular signalling cascades that promote the inflammatory response.
When 15 day-post confluent IL-1β-treated Caco-2 cell monolayers were treated for 3 h with IL-1β,
cytofluorimetric analysis with DCFDA showed a net increment of intracellular ROS levels respect to
untreated cells (Figure 4A). As a consequence, the intracellular GSH concentration, cytofluorimetrically
measured by CMFDA probe, appeared significantly decreased of about 40% (Figure 4B). Co-incubation
of the cells with IL-1β and HME in the range from 0.2 to 1.0 mg/mL manna equivalent, inhibited both
ROS generation (Figure 4A) and the GSH loss (Figure 4B) in a concentration-dependent manner. HME
at 1 mg manna equiv/mL was able to completely prevent the IL-1β-induced oxidative stress of the cells
(Figure 4).Antioxidants 2019, 8, x FOR PEER REVIEW 10 of 14 
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Figure 4. HME inhibits the generation of reactive oxygen species (A) and the GSH decay (B) in
IL-1β-activated intestinal normal-like cells. Arithmetic means ± SD (n = 9) of2’,7’-dichlorofluorescin
diacetate (DCFDA)-associated mean fluorescenc ntensity (MFI) (A) and 5-chloromethylfluorescein
diacet t (CMFDA)-associated MFI after 24 h incubation of differentiated CaC 2 cells with IL-1β
preceded by 1 h pre-treatment in the presence of HME or vehicl . Bars with diff rent letters are
significantly different with p < 0.05 (Anova associated with Tuk y test).
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3.7. Anti-Inflammatory Effects of HME in Differentiated Caco-2 Cells Stimulated by IL-1β
Following exposure to IL-1β, Caco-2 cells express and release a number of inflammatory mediators.
Release of IL-8 and IL-6 in the cell medium after IL-1β stimulation, either in the absence or in the
presence of HME, was assessed in comparison with untreated Caco-2 cells. In our experimental system,
basal levels were evaluated at 102.71 ± 18.42 and 3.26 ± 0.33 pg/mL for IL-8 and IL-6 respectively
(Figure 5A,B). Stimulation with IL-1β at 25 ng/mL for 24 h induced a 5.2-fold increase of IL-8 secretion
(534.09 ± 21.39 pg/mL), and an 8.5-fold increase (27.71 ± 3.01 pg/mL) of IL-6. Co-incubation of the
cells with HME in the range between 0.2 and 1.0 mg/mL, concentration-dependently reduced the
release of both cytokines with the system reaching control values at the highest HME concentration
(Figure 5A,B). Our results suggest that the phytocomplex of manna can attenuate the inflammatory
response of intestinal cells.
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Figure 5. HME inhibits the release of the pro-inflammatory cytokines IL-8 (A) and IL-6 (B) in
IL-1β-activated intestinal normal-like cells. Arith etic means ± SD (n = 9) of the values after 24 h
incubation of differentiated CaCo 2 cells with IL-1β preceded by 1 h pre-treatment in the presence of
HME or vehicle. Release of cytokines in the cell incubation medium was measured by ELISA. Bars
with different letters are significantly different with p < 0.05 (Anova associated with Tukey test).
4. Conclusions
The medicinal properties of Fraxinus species have long been known and find application in folk
remedies, as well as in contemp rary medicine [18,45]. Studies o the crude extracts from bark, leaves
and flowers have revealed significant antimicrobial, antioxi ative, photodynamic damage prevention,
wound healing, anti-inflammatory, immune-modulatory and antiviral activities [45]. This work reports,
for the first time, evidence regarding the bioactive properties of the sap from some Fraxinus angustifolia
Vahl, the so-called manna, which may provide a scientific basis to th long and traditionally reported
he lth benefits of this product.
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We here report the polyphenol composition of a hydro-alcholic extract of manna and demonstrate
its reducing and antioxidant capacity, in water as well as in lipid phase. HME was effective in
scavenging several reactive radicals including those derived from heme-proteins, showed lipoperoxyl
radical-scavenging capacity in solution and, more importantly, provided antioxidant protection in
complex environment as human red blood cells.
Furthermore, the manna extract showed anti-inflammatory effects in IL-1β treated Caco-2 cells,
highly regarded as a model of intestinal bowel disease.
The quite high levels of phenols/polyphenols in our extracts, with hydroxytirosol, as one of the
major components, can account for the observed reducing and free-radical scavenging properties
of manna.
Known health benefits of manna have mostly been ascribed to, and are consistent with the
properties of mannitol, an osmotically active cell-compatible polyol [46]. The antioxidative and
anti-inflammatory effects here ascertained add potential functional characteristics to this plant product.
Notwithstanding the wide array of experimental approaches employed in this work, aiming to
assess the antioxidative and anti-inflammatory potential of HME, a limitation of the present study
is related to the in vitro approach. Along these lines, and taking into account the present results
suggesting the potential for HME to control redox-regulated signaling pathways involved in cell
homeostasis, studies on the activity of manna in both normal and pathological in vivo systems are in
progress in our lab.
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